Farms.com Home   News

New Crop Missions Promote High Quality Crop, Problems Persist With Italy

 
Canada's new crop missions have wrapped up for another year.
 
Cereals Canada President Cam Dahl says they visited 18 countries this year, touring parts of Asia, Latin America, North America, Europe, The Middle East and Africa.
 
He adds they didn't have any trouble promoting this year's crop.
 
"It makes it a lot easier to talk to customers about the quality of the crop when it is in fact that good," commented Dahl. "Contrast that to last year, of course, when we had the fusarium issues. We had 95 per cent of the CWRS as number one or number two, over 90 per cent of the durum is number one and number two."
 
Dahl notes the news coming out of Italy wasn't great, as that country has yet to import any of Canada's 2017 wheat crop. He said this is due to issues surrounding country of origin labelling and an Italian public relations campaign negatively targeting Canadian durum.
 
Source : Steinbachonline

Trending Video

Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Video: Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Regulations help markets and industry exist on level playing fields, keeping consumers safe and innovation from going too far. However, incredibly strict regulations can stunt innovation and cause entire industries to wither away. Dr. Peter James Facchini brings his perspective on how existing regulations have slowed the advancement of medical developments within Canada. Given the international concern of opium poppy’s illicit potential, Health Canada must abide by this global policy. But with modern technology pushing the development of many pharmaceuticals to being grown via fermentation, is it time to reconsider the rules?

Dr. Peter James Facchini leads research into the metabolic biochemistry in opium poppy at the University of Calgary. For more than 30 years, his work has contributed to the increased availability of benzylisoquinoline alkaloid biosynthetic genes to assist in the creation of morphine for pharmaceutical use. Dr. Facchini completed his B.Sc. and Ph.D. in Biological Sciences at the University of Toronto before completing Postdoctoral Fellowships in Biochemistry at the University of Kentucky in 1992 & Université de Montréal in 1995.